<DOC>
	<DOCNO>NCT02640092</DOCNO>
	<brief_summary>The purpose protocol evaluate longitudinal change tau burden use [ 18F ] MNI-798 , tau target radiopharmaceutical compare baseline prodromal , mild , moderate AD subject similarly-aged HV subject .</brief_summary>
	<brief_title>Longitudinal Evaluation 18FMNI-798 PET Radioligand Imaging Tau Brain Patients With Alzheimer 's Disease Compared Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Males female age 5080 year Subjects early , mild moderate Alzheimer 's type dementia Alzheimer 's disease ( AD ) cohort Subjects cognitive deficit healthy control cohort Brain MRI consistent significant ischemic change pathology may interfere PET image analysis Subjects must screen PET image demonstrate amyloid bind base qualitative visual read ( AD participant ) Subjects must identify study partner willing accompany study visit Medications take symptomatic treatment AD must remain stable least 30 day prior screen visit Current prior history drug alcohol abuse Pregnant lactate woman Subjects significant psychiatric , neurological , unstable medical disorder expect interfere study Subjects unable undergo MRI , PET scan , lumbar puncture Current , past , anticipate exposure radiation , may include badged radiation exposure workplace participation nuclear medicine procedure , include research protocol last year</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>